George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 9,950 shares at $612.42 ($6.1M) on 2021-08-06, disclosed to the SEC on 2021-08-10.
Open-market sale of $6.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $611.23 | 1,000 | $611K | 10.0% |
| 2 | $611.43 | 3,000 | $1.8M | 30.1% |
| 3 | $611.43 | 3,000 | $1.8M | 30.1% |
| 4 | $612.42 | 350 | $214K | 3.5% |
| 5 | $613.01 | 1,000 | $613K | 10.1% |
| 6 | $614.00 | 1,000 |
| $614K |
| 10.1% |
| 7 | $615.00 | 600 | $369K | 6.1% |
| Total | $612.08 avg | 9,950 | $6.1M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |